Current and Former Awardees
Physician-Scientists2024 Recipients
Rahul S. Bhansali, MD
"Investigating chromatin architectural dynamics mediated by LDB1 in T-cell acute lymphoblastic leukemia"
at University of Pennsylvania Xiaoli Mi, MD
"Origin and evolution of long-lived CAR T cells in patients with hematologic malignancies"
at Memorial Sloan Kettering Cancer Center Vignesh Shanmugam, MD
"Uncovering microenvironmental dependencies in follicular lymphoma"
at Brigham and Women's Hospital Rebecca L. Zon, MD
"Defining the mechanism of thrombosis in patients with multiple myeloma"
at Dana-Farber Cancer Institute 2023 Recipients
Nicole M. Cruz, MD
"Understanding the role of KMT2D in MLL-AF9 acute myeloid leukemia"
at The Rockefeller University Mounica Vallurupalli, MD
"Defining the mechanistic implications of SF3B1 mutations in MDS"
at Dana-Farber Cancer Institute Nina Weichert-Leahey, MD
"Elucidating the role of KAT6A and KAT6B in the epigenetic reprogramming of neuroblastoma to enforce neuronal differentiation"
at Dana-Farber Cancer Institute 2022 Recipients
Wallace A. Bourgeois, MD
"Characterizing mechanisms of resistance to Menin inhibitors in KMT2A-rearranged and NPM1-mutant AML"
at Dana-Farber Cancer Institute Mark B. Leick, MD
"Engineering novel CAR T cells for AML: translating lessons from correlative studies and other diseases"
at Massachusetts General Hospital Mira A. Patel, MD
"Molecular mechanisms of human APOE-mediated myeloid cell modulation in cancer"
at The Rockefeller University 2021 Recipients
Caitlin F. Bell, MD
"Smooth muscle cell plasticity in the tumor microenvironment: another parallel between atherosclerosis and cancer"
at Stanford University School of Medicine Albert E. Kim, MD
"Using liquid biopsy and MRI to non-invasively identify therapeutic targets for brain metastases"
at Massachusetts General Hospital (Peter) Geon Kim, MD
"Elucidating the mechanisms of inflammation in clonal hematopoiesis"
at Dana-Farber Cancer Institute Max M. Wattenberg, MD
"Epigenetic reprogramming of dendritic cells for cancer immunotherapy"
at University of Pennsylvania 2020 Recipients
Elisa A. Aquilanti, MD
"Targeting telomerase in glioblastoma"
at Dana-Farber Cancer Institute Jonathan C. Dudley, MD
"Earlier detection of cancer in body cavity fluids through aneuploidy analysis after cell enrichment and partitioning"
at The Johns Hopkins University School of Medicine Dennis J. Hsu, MD
"Metabolic determinants of codon usage bias in colorectal cancer"
at University of Pittsburgh Andrew L. Ji, MD
"Cancer cell-extrinsic and intrinsic control of tumor progression and intratumoral heterogeneity"
at Stanford University School of Medicine Natalie Vokes, MD
"Dissecting tumor intrinsic and immune drivers of resistance to therapy in non-small cell lung cancer"
at The University of Texas MD Anderson Cancer Center 2019 Recipients
Edmond M. Chan, MD
"Validating a novel synthetic lethal target for microsatellite unstable cancers"
at Dana-Farber Cancer Institute Andrew J. Dunbar, MD
"Interrogating functional contribution of JAK2V617F in the maintenance of myeloproliferative neoplasms"
at Memorial Sloan Kettering Cancer Center Gabriel K. Griffin, MD
"Enhancing cancer immunotherapy through epigenetic modulation of the repetitive genome"
at Brigham and Women's Hospital Ashley K. Koegel, MD
"Engineering next generation CAR T cells to treat AML: enhancing safety through dynamic control and specificity"
at University of California, San Francisco Jonathan E. Shoag, MD
"Harnessing clinical data to identify new prostate cancer therapeutics"
at University Hospitals Cleveland Medical Center Rabi Upadhyay, MD
"Determining the distal effects of gut microbiota on the lung tumor microenvironment, cancer progression, and checkpoint blockade efficacy"
at NYU Grossman School of Medicine 2018 Recipients
Nicholas C. DeVito, MD
"Investigating the role of EMT-mediated dendritic cell tolerization in checkpoint inhibitor resistance"
at Duke University John R. Ferrarone, MD
"Seeking and evaluating novel therapeutic targets in human lung adenocarcinomas with loss-of-function mutations in LKB1"
at Weill Cornell Medicine Lillian M. Guenther, MD
"Investigation of CITED2 as a novel dependency in Ewing sarcoma"
at St. Jude Children's Research Hospital David Liu, MD
"Dissecting differential therapy response in melanoma through clinical computational oncology"
at Dana-Farber Cancer Institute Harshabad Singh, MBBS
"Epigenetic evolution of pancreatic adenocarcinoma during combination chemotherapy"
at Dana-Farber Cancer Institute 2017 Recipients
Jennifer L. Caswell-Jin, MD
"Breast cancer evolution and resistance in response to HER2-targeted therapy"
at Stanford University Christopher J. Gibson, MD
"The biology and clinical implications of clonal hematopoiesis in cancer patients"
at Dana-Farber Cancer Institute Melody Smith, MD
"CD19 targeted donor T cells improve graft versus tumor activity and reduce graft versus host disease"
at Memorial Sloan Kettering Cancer Center Sakiko Suzuki, MD
"Inflammatory cell death pathways in Myelodysplastic Syndromes"
at University of Massachusetts Medical School 2016 Recipients
Giada Bianchi, MD
"Molecular mechanisms of ROBO1 in multiple myeloma pathogenesis"
at Dana-Farber Cancer Institute Kristopher R. Bosse, MD
"GPC2 as an oncogene and immunotherapeutic target in high-risk neuroblastoma"
at Children's Hospital of Philadelphia Julia C. Carnevale, MD
"Developing new therapeutic approaches for pancreatic cancer with homologous recombination repair defects"
at University of California, San Francisco Michael W. Drazer, MD
"Defining leukemogenic mechanisms in hereditary hematologic malignancies"
at The University of Chicago David M. Kurtz, MD, PhD
"Response prediction and personalized therapy from mathematical modeling of circulating tumor DNA in non-Hodgkin lymphoma"
at Stanford University 2015 Recipients
Pavan Bachireddy, MD
"Coevolution of tumor and T cell heterogeneity following immunotherapy"
at Dana-Farber Cancer Institute Carolyn C. Jackson, MD, MPH
"Genetic dissection of pediatric classic Kaposi sarcoma"
at Memorial Sloan Kettering Cancer Center Loretta S. Li, MD
"Mechanisms of disease and resistance in CRLF2-rearranged B-cell acute lymphoblastic leukemia"
at Dana-Farber Cancer Institute 
